New combo treatment shows promise against advanced liver tumors
Disease control
Completed
This Phase 3 trial tested whether combining two established liver cancer treatments works better than using just one. Researchers compared standard chemoembolization (TACE) alone versus TACE followed by tumor ablation (RFA) in 242 patients with intermediate-stage liver cancer. Th…
Phase: PHASE3 • Sponsor: Ming Zhao • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC